PROJECT MANAGEMENT IE-1

On The Topic:

TYCOD222 SATYAM MIRGANE

TYCOD224 SARTHAK SHELAR
TYCOD212 SIDDHESHWAR REDE
 ​

CONTENT
01 INTRODUCTION

02 FINANCE

03 LIFE CYCLE

04 ANALYSIS

05 FUTURE OF NEURALINK

06 CONCLUSION
 INTRODUCTION
Neuralink is a neurotechnology company founded by Elon Musk and others to
develop brain-computer interface (BCI) technology. The company's mission is
to create a direct link between the human brain and computers, enabling
bidirectional communication. Neuralink aims to unlock new possibilities for
treating neurological conditions, enhancing human capabilities, and
potentially merging humans with artificial intelligence.

Motivation to develop brain-computer interface (BCI) technology with

the following goals:

Treating Neurological INTERDISCIPLINARY

1] 2]
Conditions TALENT

3] Symbiosis with AI UNDERSTANDING THE

4]
BRAIN
 SCOPE
The Scope of Neuralink's technology is wide-ranging and encompasses several
areas like:

1] Healthcare: Treating neurological conditions like paralysis and

Alzheimer's.
2] Augmented Human Capabilities: Enhancing memory, cognition, and
sensory perception.
3] Research and Understanding: Advancing neuroscience knowledge.
4] Human-Machine Interaction: Revolutionizing how humans interact with
computers.
5] Ethical and Societal Implications: Addressing privacy, autonomy, and
equity concerns.
 Design
​

Initial design and development of the neural implant.

Testing

LIFE
​ Extensive testing of the implant's functionality and safety.

CYCLE Manufacturing

Mass production of the implant for widespread availability.

Human Trials

Scheduled to start for neurological disorder treatments.

Deployment

Implementation of the implant in patients and continuous

monitoring.
 Finance
​

Funding Rounds:
-Series A (2017): Raised $31M, led by DFJ Growth and Founders Fund. Used for
initial
R&D and recruiting talent.
-Series B (2019): Raised $158M, led by Andreessen Horowitz and Paradigm.
Funded
development of Neuralink Link v0.9 and animal testing.
-Series C (2020): Raised $205M, led by Vy Capital and Baillie Gifford. Supported
clinical trials and manufacturing infrastructure.
Elon Musk's investments and guidance, Synchron collaboration, and academic
partnerships drive growth. Revenue streams include product sales, licensing, and
subscriptions.
Neuralink's private status limits financial transparency. Market opportunities
​
include medical, consumer, and research applications. Future success hinges on
regulatory approval and strategic partnerships.
 ANALYSIS OF NEURALINK
​

CONSTRAINS
​
SUCCESS ​

TECHNICAL VISIONARY
​

COMPLEXITY ​
LEADERSHIP

​
BIO INTERDISCIPLINARY
​ ​

COMPATIBILITY ​

TALENT

​
REGULATORY SUSTAINABLE
HURDLES FUNDING
​

​
 Future of Neurolink
1 2 3

Mass Research Ethical

Adoption Expansion Considerations
Integration into Continued research for Addressing concerns
mainstream healthcare new applications and related to privacy,
and consumer tech improved technology. safety, and autonomy.
products.
 Conclusion

CONNECTING NEURALINK WITH

PRINCIPLES OF MANAGEMENT
​